186 related articles for article (PubMed ID: 18429952)
21. Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness.
Cadoux M; Caruso S; Pham S; Gougelet A; Pophillat C; Riou R; Loesch R; Colnot S; Nguyen CT; Calderaro J; Celton-Morizur S; Guerra N; Zucman-Rossi J; Desdouets C; Couty JP
J Hepatol; 2021 Jun; 74(6):1386-1397. PubMed ID: 33484773
[TBL] [Abstract][Full Text] [Related]
22. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
[TBL] [Abstract][Full Text] [Related]
23. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.
Lu D; Han C; Wu T
Oncogene; 2012 Feb; 31(7):842-57. PubMed ID: 21743491
[TBL] [Abstract][Full Text] [Related]
24. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
25. The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex.
Guo RJ; Funakoshi S; Lee HH; Kong J; Lynch JP
Carcinogenesis; 2010 Feb; 31(2):159-66. PubMed ID: 19734199
[TBL] [Abstract][Full Text] [Related]
26. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
Kang DW; Min do S
PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
[TBL] [Abstract][Full Text] [Related]
27. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
[TBL] [Abstract][Full Text] [Related]
28. SOX10 is a novel oncogene in hepatocellular carcinoma through Wnt/β-catenin/TCF4 cascade.
Zhou D; Bai F; Zhang X; Hu M; Zhao G; Zhao Z; Liu R
Tumour Biol; 2014 Oct; 35(10):9935-40. PubMed ID: 25001176
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
30. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Liu L; Wu J; Wang S; Luo X; Du Y; Huang D; Gu D; Zhang F
Exp Cell Res; 2017 Sep; 358(2):209-216. PubMed ID: 28648520
[TBL] [Abstract][Full Text] [Related]
31. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
32. Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability.
Lin Z; He R; Luo H; Lu C; Ning Z; Wu Y; Han C; Tan G; Wang Z
J Exp Clin Cancer Res; 2018 Jan; 37(1):17. PubMed ID: 29386044
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.
Zhang X; Yang Y; Liu X; Herman JG; Brock MV; Licchesi JD; Yue W; Pei X; Guo M
Epigenetics; 2013 Apr; 8(4):373-82. PubMed ID: 23449122
[TBL] [Abstract][Full Text] [Related]
34. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis.
Feng H; Cheng AS; Tsang DP; Li MS; Go MY; Cheung YS; Zhao GJ; Ng SS; Lin MC; Yu J; Lai PB; To KF; Sung JJ
J Clin Invest; 2011 Aug; 121(8):3159-75. PubMed ID: 21747169
[TBL] [Abstract][Full Text] [Related]
36. miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9.
Yang C; Xu Y; Cheng F; Hu Y; Yang S; Rao J; Wang X
Cell Death Dis; 2017 Aug; 8(8):e2999. PubMed ID: 28817119
[TBL] [Abstract][Full Text] [Related]
37. Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis.
Kato T; Satoh S; Okabe H; Kitahara O; Ono K; Kihara C; Tanaka T; Tsunoda T; Yamaoka Y; Nakamura Y; Furukawa Y
Neoplasia; 2001; 3(1):4-9. PubMed ID: 11326310
[TBL] [Abstract][Full Text] [Related]
38. Krüppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma.
Yang T; Cai SY; Zhang J; Lu JH; Lin C; Zhai J; Wu MC; Shen F
PLoS One; 2012; 7(6):e39668. PubMed ID: 22761862
[TBL] [Abstract][Full Text] [Related]
39. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
[TBL] [Abstract][Full Text] [Related]
40. Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction.
Gan XQ; Wang JY; Xi Y; Wu ZL; Li YP; Li L
J Cell Biol; 2008 Mar; 180(6):1087-100. PubMed ID: 18347071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
